No Data
No Data
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US
Quantum BioPharma Closes Private Placement Offering
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
Quantum Biopharma Regains Nasdaq Compliance
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
No Data
No Data